Feng Z - Search Results

1

NFKB1 as a key player in Tumor biology: from mechanisms to therapeutic implications.

Song Z, Feng Z, Wang X, Li J, Zhang D. Song Z, et al. Among authors: feng z. Cell Biol Toxicol. 2025 Jan 11;41(1):29. doi: 10.1007/s10565-024-09974-2. Cell Biol Toxicol. 2025. PMID: 39797972 Free PMC article. Review.

2

A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression.

Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W, Wu X. Feng Z, et al. Sci Rep. 2016 May 3;6:25408. doi: 10.1038/srep25408. Sci Rep. 2016. PMID: 27139372 Free PMC article.

3

Hormone receptor expression profiles differ between primary and recurrent high-grade serous ovarian cancers.

Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W, Wu X. Feng Z, et al. Oncotarget. 2017 May 16;8(20):32848-32855. doi: 10.18632/oncotarget.15858. Oncotarget. 2017. PMID: 28416763 Free PMC article.

4

Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma via IL6-JAK2/STAT3 Signaling Pathway Under Hypoxia.

Han X, Lu Y, Li X, Xia L, Wen H, Feng Z, Ju X, Chen X, Wu X. Han X, et al. Among authors: feng z. Front Oncol. 2021 Mar 9;11:643986. doi: 10.3389/fonc.2021.643986. eCollection 2021. Front Oncol. 2021. PMID: 33768003 Free PMC article.

5

Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer.

Cao L, Wen H, Feng Z, Han X, Zhu J, Wu X. Cao L, et al. Among authors: feng z. Int J Gynecol Cancer. 2021 Jan;31(1):52-58. doi: 10.1136/ijgc-2020-001974. Epub 2020 Dec 10. Int J Gynecol Cancer. 2021. PMID: 33303568

6

Metastatic patterns do not provide additional prognostic information for patients with FIGO stage IV high-grade serous ovarian cancer.

Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W, Wu X. Feng Z, et al. J Surg Oncol. 2020 Aug;122(2):315-319. doi: 10.1002/jso.25941. Epub 2020 Jun 4. J Surg Oncol. 2020. PMID: 32500598

7

Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer.

Cao L, Wen H, Feng Z, Han X, Wu X. Cao L, et al. Among authors: feng z. Int J Gynecol Cancer. 2019 Oct;29(8):1244-1251. doi: 10.1136/ijgc-2019-000556. Epub 2019 Aug 17. Int J Gynecol Cancer. 2019. PMID: 31422351

8

Homologous recombination repair gene mutations show no survival benefits in Chinese high-grade serous ovarian cancer patients.

Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W, Wu X. Feng Z, et al. Ann Transl Med. 2021 Mar;9(5):364. doi: 10.21037/atm-20-5136. Ann Transl Med. 2021. PMID: 33842585 Free PMC article.

9

Germline Mutational Landscape and Novel Targetable RAD51D Variant in Chinese Patients With Ovarian Cancer.

Feng Z, Chen S, An N, Xiu Z, Ju X, Chen X, Bi R, Wang J, Zhu S, Wu X, Wen H. Feng Z, et al. JCO Glob Oncol. 2024 Jun;10:e2300454. doi: 10.1200/GO.23.00454. JCO Glob Oncol. 2024. PMID: 38905575

10

Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer.

Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W, Wu X. Feng Z, et al. PLoS One. 2016 May 20;11(5):e0156101. doi: 10.1371/journal.pone.0156101. eCollection 2016. PLoS One. 2016. PMID: 27203425 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,296 results

Search Page

Filters